 Arden Trust Co bought a new position in Aimmune Therapeutics Inc NASDAQ:AIMT in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 7,831 shares of the biotechnology companys stock, valued at approximately 113,000. Other large investors have also modified their holdings of the company. ... 